| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1004882735 |
| P356 | DOI | 10.1038/ONC.2012.385 |
| P8608 | Fatcat ID | release_s2cullb555d37h53cqln75k4pi |
| P953 | full work available at URL | https://www.nature.com/articles/onc2012385 |
| https://www.nature.com/articles/onc2012385.pdf | ||
| P698 | PubMed publication ID | 22964633 |
| P50 | author | Päivi M Ojala | Q56112086 |
| Christina B Karsten | Q56525462 | ||
| Thomas F Schulz | Q61072935 | ||
| P2093 | author name string | W. Jäger | |
| D. Steinemann | |||
| G. Sarek | |||
| M. Pietrek | |||
| S. Kati | |||
| S. Santag | |||
| P2860 | cites work | TAp73 knockout shows genomic instability with infertility and tumor suppressor functions | Q36919913 |
| The jury is in: p73 is a tumor suppressor after all. | Q37285304 | ||
| Skin human papillomavirus type 38 alters p53 functions by accumulation of deltaNp73. | Q38317007 | ||
| Distinct regulation of p53 and p73 activity by adenovirus E1A, E1B, and E4orf6 proteins | Q39446048 | ||
| Viral oncoproteins discriminate between p53 and the p53 homolog p73. | Q39576424 | ||
| Persistent Infection of Epstein-Barr Virus-Positive B Lymphocytes by Human Herpesvirus 8 | Q39581248 | ||
| Distinct p53, p53:LANA, and LANA complexes in Kaposi's Sarcoma--associated Herpesvirus Lymphomas | Q39744147 | ||
| A Domain in the C-terminal region of latency-associated nuclear antigen 1 of Kaposi's sarcoma-associated Herpesvirus affects transcriptional activation and binding to nuclear heterochromatin | Q39756815 | ||
| An essential role for p73 in regulating mitotic cell death | Q39763275 | ||
| Accumulation of LANA at nuclear matrix fraction is important for Kaposi's sarcoma-associated herpesvirus replication in latency | Q39913167 | ||
| Transcriptional activation by the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen is facilitated by an N-terminal chromatin-binding motif. | Q39960021 | ||
| Identification and characterization of the product encoded by ORF69 of Kaposi's sarcoma-associated herpesvirus | Q40008314 | ||
| The viral interferon-regulatory factor-3 is required for the survival of KSHV-infected primary effusion lymphoma cells | Q40077157 | ||
| A novel role for p73 in the regulation of Akt-Foxo1a-Bim signaling and apoptosis induced by the plant lectin, Concanavalin A. | Q40118545 | ||
| Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen induces chromosomal instability through inhibition of p53 function | Q40335991 | ||
| Inhibiting primary effusion lymphoma by lentiviral vectors encoding short hairpin RNA. | Q40486158 | ||
| The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus modulates cellular gene expression and protects lymphoid cells from p16 INK4A-induced cell cycle arrest | Q40496132 | ||
| Characterization of a novel HHV-8-positive cell line reveals implications for the pathogenesis and cell cycle control of primary effusion lymphoma | Q40865709 | ||
| Kaposi's sarcoma-associated herpesvirus confers a survival advantage to endothelial cells | Q42141115 | ||
| Kaposi's sarcoma-associated herpesvirus induction of chromosome instability in primary human endothelial cells | Q42328529 | ||
| Expression of p53 and human herpesvirus-8 (HHV-8)-encoded latency-associated nuclear antigen with inhibition of apoptosis in HHV-8-associated malignancies | Q42665921 | ||
| Kaposi's sarcoma herpesvirus lytic replication compromises apoptotic response to p53 reactivation in virus-induced lymphomas. | Q45358610 | ||
| Functional impairment of p73 and p51, the p53-related proteins, by the human T-cell leukemia virus type 1 Tax oncoprotein | Q45744096 | ||
| c-Abl tyrosine kinase selectively regulates p73 nuclear matrix association | Q47807561 | ||
| HDM2 antagonist Nutlin-3 disrupts p73-HDM2 binding and enhances p73 function. | Q52581241 | ||
| Human delta Np73 regulates a dominant negative feedback loop for TAp73 and p53. | Q53393697 | ||
| Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins | Q24290998 | ||
| Mdm2 promotes the rapid degradation of p53 | Q24322597 | ||
| Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53 | Q24328775 | ||
| MDM2 suppresses p73 function without promoting p73 degradation | Q24554510 | ||
| In vivo activation of the p53 pathway by small-molecule antagonists of MDM2 | Q27642888 | ||
| Regulation of p53 stability by Mdm2 | Q27860744 | ||
| Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma | Q28242984 | ||
| Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas | Q28299069 | ||
| p53 mutations in human cancers | Q28302973 | ||
| Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53 | Q29615851 | ||
| EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors | Q33261811 | ||
| Small-molecule RETRA suppresses mutant p53-bearing cancer cells through a p73-dependent salvage pathway. | Q33329474 | ||
| The K-bZIP protein from Kaposi's sarcoma-associated herpesvirus interacts with p53 and represses its transcriptional activity. | Q33813261 | ||
| Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53 | Q33834993 | ||
| Modulation of cellular and viral gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus | Q33835021 | ||
| Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus binds to p53 and represses p53-dependent transcription and apoptosis. | Q33842636 | ||
| Kaposi's sarcoma-associated herpesvirus open reading frame 50 represses p53-induced transcriptional activity and apoptosis | Q33842738 | ||
| p53 inhibition by the LANA protein of KSHV protects against cell death | Q33885642 | ||
| Brd2/RING3 interacts with a chromatin-binding domain in the Kaposi's Sarcoma-associated herpesvirus latency-associated nuclear antigen 1 (LANA-1) that is required for multiple functions of LANA-1. | Q34092739 | ||
| NF-kappaB inhibits T-cell activation-induced, p73-dependent cell death by induction of MDM2 | Q34241420 | ||
| Functional regulation of p73 and p63: development and cancer | Q35601815 | ||
| Functional p53 signaling in Kaposi's sarcoma-associated herpesvirus lymphomas: implications for therapy. | Q35635426 | ||
| Reactivation of the p53 pathway as a treatment modality for KSHV-induced lymphomas. | Q35664106 | ||
| KSHV vFLIP is essential for the survival of infected lymphoma cells | Q36399405 | ||
| P433 | issue | 32 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | primary effusion lymphoma | Q3832899 |
| Kaposi's sarcoma | Q725345 | ||
| P304 | page(s) | 3676-3685 | |
| P577 | publication date | 2012-09-10 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | Recruitment of the tumour suppressor protein p73 by Kaposi's Sarcoma Herpesvirus latent nuclear antigen contributes to the survival of primary effusion lymphoma cells | |
| Recruitment of the tumour suppressor protein p73 by Kaposi’s Sarcoma Herpesvirus latent nuclear antigen contributes to the survival of primary effusion lymphoma cells | |||
| P478 | volume | 32 |
| Q35973676 | A Screen for Extracellular Signal-Regulated Kinase-Primed Glycogen Synthase Kinase 3 Substrates Identifies the p53 Inhibitor iASPP. |
| Q26743368 | Activation of DNA Damage Response Induced by the Kaposi's Sarcoma-Associated Herpes Virus |
| Q40161262 | Antimicrobial sulfonamides clear latent Kaposi sarcoma herpesvirus infection and impair MDM2-p53 complex formation. |
| Q26749612 | Cell Cycle Regulatory Functions of the KSHV Oncoprotein LANA |
| Q39152964 | Effects of the NEDD8-activating enzyme inhibitor MLN4924 on lytic reactivation of Kaposi's sarcoma-associated herpesvirus |
| Q39046899 | Epstein-Barr virus nuclear antigen 3C interact with p73: Interplay between a viral oncoprotein and cellular tumor suppressor |
| Q58778363 | Gene essentiality landscape and druggable oncogenic dependencies in herpesviral primary effusion lymphoma |
| Q30379938 | Genomic analysis of xCT-mediated regulatory network: Identification of novel targets against AIDS-associated lymphoma. |
| Q34020096 | How do viruses trick B cells into becoming lymphomas? |
| Q92340148 | In Vivo Models of Oncoproteins Encoded by Kaposi's Sarcoma-Associated Herpesvirus |
| Q26742030 | KSHV-Mediated Angiogenesis in Tumor Progression |
| Q33632932 | Kaposi Sarcoma Herpesvirus (KSHV) Latency-Associated Nuclear Antigen (LANA) recruits components of the MRN (Mre11-Rad50-NBS1) repair complex to modulate an innate immune signaling pathway and viral latency |
| Q40046587 | Kaposi sarcoma herpesvirus pathogenesis. |
| Q40127660 | Kaposi's sarcoma-associated herpesvirus stably clusters its genomes across generations to maintain itself extrachromosomally. |
| Q38859450 | Kaposi's sarcoma-associated herpesvirus-encoded LANA contributes to viral latent replication by activating phosphorylation of survivin |
| Q90319823 | Molecular Biology of KSHV in Relation to HIV/AIDS-Associated Oncogenesis |
| Q39795782 | ORF57 overcomes the detrimental sequence bias of Kaposi's sarcoma-associated herpesvirus lytic genes |
| Q96348276 | Regulating tumor suppressor genes: post-translational modifications |
| Q36152200 | Regulation of the Abundance of Kaposi's Sarcoma-Associated Herpesvirus ORF50 Protein by Oncoprotein MDM2 |
| Q40250970 | SIRT1 and AMPK pathways are essential for the proliferation and survival of primary effusion lymphoma cells |
| Q26771969 | The KSHV RNA regulator ORF57: target specificity and its role in the viral life cycle |
| Q91996237 | The interplay between Epstein-Bar virus (EBV) with the p53 and its homologs during EBV associated malignancies |
Search more.